Global Digestive Enzymes Market, By Drugs (Pancrelipase, Lactase, Others), Indication (Pancreatic Exocrine Dysfunction, Cystic Fibrosis, Chronic Pancreatitis, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Digestive Enzymes Market Analysis and Size
The global digestive enzymes market is expected to witness significant growth during the forecast period. Numerous factors, such as changing lifestyles, hectic work schedules, and overtime at workplaces, are foremost consumers towards packaged food, which often results in digestive problems. The demographic trend toward an aging population represents a rising need for managing disorders, such as gastrointestinal tract obstructions. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global digestive enzymes market in the forecast period 2022-2029. The expected CAGR of global digestive enzymes market is tend to be around 9.2% in the mentioned forecast period. The market was valued at USD 699.40 million in 2021, and it would grow upto USD 1414.19 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Digestive enzymes help to break food substances for smooth digestion. These proteins accelerate chemical reactions that turn nutrients into substances so the digestive tract can absorb them. These enzymes are generally given orally to improve digestion in patients suffering from various gastrointestinal tract disorders as the pancreas is insufficient of producing the required amounts of digestive enzymes such as amylase, gelatinase, lactase and others.
Digestive Enzymes Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Drugs (Pancrelipase, Lactase, Others), Indication (Pancreatic Exocrine Dysfunction, Cystic Fibrosis, Chronic Pancreatitis, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Bayer AG (Germany), Abbott (U.S.), AbbVie Inc. (U.S.), Merck KGaA (Germany), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), VIVUS LLC. (U.S.), Amano Enzyme USA Co., Ltd. (Japan), Trumac Healthcare (India)
|
|
Market Opportunities
|
|
Global Digestive Enzymes Market Dynamics
Drivers
- Increased Positive Inclination Towards Sports
The positive viewpoint towards sports nutrition and rising concerns associated with stomach health boosts market growth. Growing number of global sports event, including the Big Bash League, NBA, English Premier League, and Indian Primer League have forced athletes to focus on maintaining their physical strength, which is projected to stimulate growth over the upcoming years. This boosts the market growth.
- Higher Adoption of Organic Foods
Growing consumer awareness associated with the adverse impact of inorganic food on human health has shifted industry trend toward promoting organic food market. Additionally, the growing consumption of organic foods for providing nutritional benefits is expected to prevent consumers from choosing dietary supplements in the form of capsules and tablets. This boosts the market growth.
Opportunities
- Higher Cases of Gastrointestinal Disorders
Growing cases of gastrointestinal disorders worldwide is one of the major drivers contributing to the segment growth. For instance, as per the study titled, "Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study" published in January 2021, above 40.0% of people worldwide have functional gastrointestinal disorders which affect quality of life and health care use. This is another factor expected to drive growth of the digestive enzymes market.
- Higher Demand of Growth Strategies
Several key players are involved in numerous growth strategies, such as collaborations, partnerships, agreements, and mergers and acquisitions, that are projected to boost the market. For instance, in May 2020, Nestlé Health Science (NHSc) declared the successful completion of the asset purchase of Zenpep and Viokace, expanding NHSc’s portfolio. ZENPEP and VIOKACE, available in the U.S., are a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency.
Restraints/Challenges
- Impending Drug Approvals
Some many drugs or injections waiting for approval of the drugs. Receiving approval for the drug from regulatory authorities is a very tedious and challenging task as regulatory authorities such as the U.S. FDA execute substantial and burdensome requirements upon companies involved in the clinical development, marketing, manufacturing, and distribution of drugs
- Restrictions Against Animal Killing
Various restrictions against animal killing are imposed in countries such as the United States, Australia, Canada, and the United Kingdom, and several NGOs are raising concerns about animal-derived digestive enzyme supplements. All these factors are expected to have a negative impact on digestive enzymes, which is obstructing the market growth.
This global digestive enzymes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global digestive enzymes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Digestive Enzymes Market
COVID-19 left a major impact on industry growth during the forecast period. Growing gastrointestinal symptoms among patients who have suffered from COVID-19 positively impacted the market in later times. As per the study titled, "Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome" published in December 2020, COVID-19 patients witnessed gastrointestinal symptoms such as anorexia (17.9%), nausea (17.9%), and diarrhea (24.2%). Additionally, it also stated that in patients who suffered majorly from COVID-19, the symptoms of gastrointestinal disorders became more prominent.
Recent Developments
- In June, 2022, the kiwi regularity chewable was introduced by Enzymedica, a Florida-based firm that provides high-quality natural digestive solutions. Zespri kiwis are notable for having a advanced level of UV light exposure that causes the plants to produce more beneficial secondary metabolites like polyphenols and carotenoids as a result of their location.
- In February 2022, Mimi's Rock Corp. announced that its supplements brand, Dr. Tobias, is increasing its product portfolio with digestive enzymes with prebiotics and probiotics to support gut health developed to meet rising market demand in the digestive health space.
Global Digestive Enzymes Market Scope
The global digestive enzymes market is segmented on the basis of drugs, indication, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drugs
- Pancrelipase
- Lactase
- Others
Indication
- Pancreatic Exocrine Dysfunction
- Cystic Fibrosis
- Chronic Pancreatitis
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Digestive Enzymes Market Regional Analysis/Insights
The global digestive enzymes market is analysed and market size insights and trends are provided by drugs, indication, distribution channel and end-user as referenced above.
The major countries covered in the global digestive enzymes market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for global digestive enzymes market throughout the forecasted period due to the increase prevalence of digestive disorders and advanced healthcare facilities supported by reimbursement policies.
Asia-Pacific dominates the market due to the increase government funding and awareness.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Digestive Enzymes Market Share Analysis
The global digestive enzymes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global digestive enzymes market.
Key players operating in the global digestive enzymes market include:
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Abbott (U.S.)
- AbbVie Inc. (U.S.)
- Merck KGaA (Germany)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
- Hikma Pharmaceuticals PLC (U.K.)
- VIVUS LLC. (U.S.)
- Amano Enzyme USA Co., Ltd. (Japan)
- Trumac Healthcare (India)
SKU-